March 26, 2021
Member/Center Highlights
Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
Notice of Changes to NIH Biosketches, Other Support page
To support strong collaboration between Federal research agencies, NIH has made every effort to align the Biographical Sketch (Biosketch), Other Support format page, and Application Form Instructions with the guidance issued by the Office of Science and Technology Policy Joint Committee on the Research Environment. As a result, NIH has released a notice (NOT-OD-21-073) that outlines updates to application forms and instructions to support applicants and recipients' need to provide full transparency and disclosure of all research activities, foreign and domestic. The updated form and instructions will be required for use for applications and Research Performance Progress Reports (RPPRs) submitted for due dates on or after May 25, 2021.
Overview of Changes

Biographical Sketch Format Page Changes
  • Section B "Positions and Honors" has been renamed "Positions, Scientific Appointments, and Honors."
  • For the non-Fellowship Biosketch, Section D has been removed.
  • For the Fellowship Biosketch, Section D has been updated to remove "Research Support."
  • As applicable, all applicants may include details on ongoing and completed research projects from the past three years that they want to draw attention to within the personal statement, Section A.
  • Other Support Format Page Changes: The format page has been re-organized to separate funded projects from in-kind contributions.
  • Signature block added for Program Director/Principal Investigator or Other Senior/Key
  • Personnel to certify the accuracy of the information submitted. Each PD/PI or senior/key personnel must electronically sign their respective Other Support form as a PDF before submission.

Supporting Documentation
  • For Other Support submissions that include foreign activities and resources, recipients are required to submit copies of contracts, grants, or any other agreement specific to senior/key personnel foreign appointments and/or employment with a foreign institution as supporting documentation. If they are not in English, recipients must provide translated copies. This supporting documentation must be provided as part of the Other Support PDF following the Other Support Format page.

We want to alert you that the changes to the Other Support requirements are significant and much more than simply a change in format. You should review the new template and take some time to read NIH’s FAQ page about the Other Support requirements.

Above all, you should work with your department administrator to update your Other Support documentation now, so that you have it readily available if it is requested by the Cancer Center research administration team for an upcoming progress report or grant proposal. If you have any questions about the new Other Support page and your own department administrator cannot assist, we are happy to help you update or create yours before you’re hit with a deadline! Please reach out to and let us know if you have questions or need assistance.

Save the Date: Submitting your NIH grant proposals Workshop on April 21

Avoid errors and warnings during submissions by joining the SOM Office of Research Administration on Wednesday, April 21 from 12-1:30 pm for a workshop to help faculty navigate and understand NIH policies for submitting grant proposals! The recently released NIH guidelines for Biosketches and Other Support pages will also be discussed in detail. The 90-minute virtual session will be led by Erin Fogarty, Assistant Dean for Research Administration, and staff from the SOM Office of Grants and Contracts. Registration details will be available soon - email Maita Diaz with questions.
Case Comprehensive Cancer Center welcomes new external advisory committee members
We are pleased to announce four new appointments to our External Advisory Committee. We look forward to introducing them to our center and will look to them for guidance as we begin to prepare for our center grant renewal.

Anita Y. Kinney, PhD is associate director for cancer health equity and engagement at Rutgers Cancer Institute of New Jersey and director of ScreenNJ, a statewide cancer prevention and screening program. She is also a professor in the Department of Biostatistics and Epidemiology and director of the Center for Cancer Health Equity at the School of Public Health at Rutgers University.

Adekunle "Kunle" Odunsi, MD, PhD was appointed director of the University of Chicago Medicine Comprehensive Cancer Center effective March 1, 2021 and is Biological Sciences Division Dean for Oncology and Professor of Obstetrics and Gynecology at the University of Chicago.

Vanessa Sheppard, PhD serves as associate director for Community Outreach Engagement and Health Disparities at Virginia Commonwealth University (VCU) Massey Cancer Center. She is also chair of the Department of Health Behavior and Policy at VCU.

Aleksandar Zafirovski, MBA is the executive director and associate director for Administration at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Left to right: Anita Kinney, Kunle Odunsi, Vanessa Sheppard and Aleksandar Zafirovski
We also wish to thank our departing members, Deborah Erwin, PhD and Theodore Yank, MHA, for their years of service. Their advice, expertise and open comments helped to strengthen our center and lead us in the right direction.
New technology matching patients genetic testing with available clinical trials nationwide arrives at University Hospitals
Cleveland-based GenomOncology and University Hospitals (UH) Seidman Cancer Center have entered into a market-leading partnership to increase clinical trial accrual rates. Utilizing GenomOncology's Precision Decision and GO Connect solutions, UH will be able to automate the patient analysis and treatment matching process to help scale their precision oncology program.
Sen Gupta leads team to advance bioinspired nanotechnology to enhance blood clotting, awarded $2.1M by NIH
From The Daily: A team of researchers, led by biomedical engineering professor Anirban Sen Gupta, PhD is working toward innovating and advancing platelet-inspired nanotechnology systems to treat severe bleeding in surgery and trauma.

The National Institutes of Health (NIH) has awarded a $2.1 million, four-year research grant to Sen Gupta and collaborators at the University of Michigan and University of North Carolina, to advance the design of artificial platelets that can promote and stabilize clots to stop bleeding. Dr. Sen Gupta is a member of the Case Comprehensive Cancer Center's Cancer Imaging Program.
Open positions at the Center for Immunotherapy and Precision Immuno-Oncology 
The Center for Immunotherapy and Precision Immuno-Oncology (CITI) at Cleveland Clinic Lerner Research Institute is currently seeking a postdoc, a computational biologist and faculty in translational cell based therapies for neurological disorders.
What's Coming Up
Mark Your Calendar
Cancer Center Seminar Series
TODAY, March 26, 2021, 12p via Zoom
Today's Cancer Center Seminar features Zhenghe John Wang, PhD presenting, "Targeting PIK3CA-mutant colorectal cancer" on behalf of the GI Cancer Genetics Program at noon via Zoom.

Dr. Wang is Vice Chair for Faculty Development and professor in the Department of Genetics and Genome Sciences, the Dale H. Cowan MD - Ruth Goodman Blum Professor of Cancer Research and Co-Leader of the Case Comprehensive Cancer Center's GI Cancer Genetics Program at Case Western Reserve University School of Medicine.
Cancer Center Seminar Series
Friday, April 9, 2021, 12p via Zoom
There will be no Cancer Center Seminar next Friday, April 2.

Our series returns on Friday, April 9 with Susan Mazanec, PhD, RN presenting on behalf of the Cancer Prevention Control & Population Research Program.

Dr. Mazanec is an assistant professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University and a member of the Case CCC's Cancer Prevention Control & Population Research Program.
Clinical Research Retreat
May 5, 2021, 5-7p | Virtual
Registration is now open for the Spring Clinical Research Retreat! This retreat will focus on cancer imaging in clinical trials.

Anant Madabhushi, PhD will present, "Artificial Intelligence in Radiology: Decision Support tools for the Oncologist" and Nikhil Ramaiya, MD will present, "Role of Imaging in Cancer Clinical Trials and Beyond" during the retreat.
Save the Date! Annual Scientific Retreat
July 22-23, 2021 | Virtual
The 2021 Annual Scientific Retreat for members and trainees is scheduled for July 22-23!

As you may know, this is one of the few times a year our entire center is able to enjoy the company of one another and collaborate.

Registration information, agenda and retreat logistics will be posted in this weekly newsletter and distributed via email to members closer to the retreat.
VeloSano 8 Bike to Cure Weekend
September 10-12, 2021

We are looking ahead with optimism to VeloSano 8 (2021), with a goal of providing opportunities to reunite our VeloSano community in a variety of safe and meaningful ways!

VeloSano is offering options for anyone to participate in any way they are most comfortable - whether riding with us during "Bike to Cure" weekend September 10-12; riding virtually, or by choosing your own activity to participate anytime, anywhere as a Virtual Fundraiser.

The Case Comprehensive Cancer Center, Team Case CCC, will be joining VeloSano again this year and providing complimentary registration and jerseys for its riders. Please contact team captains Caroline El Sanadi or Mary Wright for the registration waiver or code with any questions!
Additional Upcoming Events
AACR Annual Meeting 2021
April 10-15 and May 17-21, 2021 | Virtual
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

Regular abstracts and the meeting itinerary planner are now available.
Cell-Based Therapies and Tissue Engineering Short Course
May 19-20, 2021
The Skeletal Research Center and the Department of Biology of Case Western Reserve University are pleased to present the twentieth annual short course entitled: “Cell-Based Therapies and Tissue Engineering”, running from May 19 through May 20, 2021.

Registration is now open. The 2021 program is here. To download a flyer, please click here.

Who Should Attend:
This course is intended for graduate students, post-graduate students and health science professionals who are interested in tissue engineering and regenerative medicine approaches with emphasis on translational research principles and protocols used or being modeled for direct clinical use.
2021 Race for the Place
June 6, 2021 | Virtual
Race for the Place in support of The Gathering Place, takes place the first Sunday in June on National Cancer Survivors Day. The Race, a 5K and 1 Mile walk, is a wonderful celebration of cancer survivors and an opportunity to raise money to support the free programs and services provided at The Gathering Place to help children, teens, adults, individuals, families and friends cope while on the cancer journey.

Registration is now open!
AACI Clinical Research Innovation 13th Annual Meeting
July 13-15, 2021 | Virtual
Registration is now open for the 13th Annual AACI CRI Meeting, Adapting Clinical Trials Offices for 2021 and Beyond which will be held virtually July 13-15. The program will provide panel discussions with content experts and breakout sessions for our members and abstract winners and runners-up will be acknowledged in poster sessions.

Abstract Deadline March 15
The CRI Steering Committee is currently soliciting abstracts for the CRI meeting. Abstracts inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers.

More information, including the program and registration, is now available on the CRI meeting website.
Funding Opportunities
Deadlines vary by award

Available award: Up to $40,000
LOI Deadline: March 26, 2021

Available award: $75,000 for one year
LOI Deadline: April 2, 2021

Available award: Up to $120,000 for one year
Deadline: April 16, 2021

Available award: $75,000 for 18 months
Deadline: April 16, 2021

Available award: $180,000 for 18 months
Deadline: April 16, 2021

Available award: $25,000 for one year
Applications accepted and awarded on a rolling basis

Proposals are accepted on a rolling basis subject to fund availability

Available award: up to $150,000
Proposals are accepted on a rolling basis
LOI Deadline: April 16, 2021

The 2022 Harrington Scholar-Innovator Award is now open and accepting Letters of Intent. The award offers inventive physician-scientists resources and expertise to advance their discoveries into medicines. Intellectual property rights are retained by the award recipient or his or her institution. Up to 10 applicants will be selected to receive:

  • $100,000 guaranteed; opportunity to qualify for up to $700,000.
  • Drug and business development support from Harrington Discovery Institute’s Therapeutics Development Center (pharma-experienced industry leaders with a track record of bringing drugs to market).
  • A personalized team and project manager dedicated to each scholar.

The call is open to physician-scientists at accredited academic medical centers, research institutions and universities in the United States and Canada. Selection criteria include innovation, creativity and potential for impact on human health. Applicants must have a doctorate in medicine. Award recipients will be selected by the Harrington Discovery Institute’s Scientific Advisory Board and announced in first quarter of 2022.
In The News
Harvard Medical School - March 12, 2021
Anant Madabhushi, PhD, is quoted in the article for his insight on the potential impacts AI can have on the optimization of both diagnostic and prognostic clinical decisions. Dr. Madabushi is Director of the Center for Computational Imaging and Personalized Diagnostics at Case Western Reserve University and member of the Case CCC.
News Medical - March 23, 2021
"Our findings provide the technical means and conceptual basis for a new molecular-based approach that could become key to the clinical management of this disease," said Sanford Markowitz, MD, PhD.
From The NIH
ICYMI: 5th Virtual Meeting of NCI Board of Scientific Advisors
National Cancer Institute Logo
This 5th virtual meeting of the National Cancer Institute (NCI) Board of Scientific Advisors (BSA) was held last week. The next virtual meeting will be the 4th virtual joint meeting of the NCI's BSA and National Cancer Advisory Board (NCAB) June 13-15, 2021. While minutes from the meeting are forthcoming, recordings and individual presentations are linked below.
NCI supports NIH Effort to End Structural Racism in Biomedical Research
On March 1, Francis S. Collins, MD, PhD director of the National Institutes of Health, launched a new initiative designed to end structural racism in biomedical research called UNITE. In his statement, Dr. Collins committed NIH to instituting new ways to support diversity, equity, and inclusion, and identifying and dismantling any policies and practices that may harm our workforce and our science.

As part of this initiative NIH has issued a Request for Information seeking input on practical and effective approaches to improve and strengthen racial equity, diversity, and inclusion across all facets of the biomedical research enterprise, both within NIH and the external community, and expand research to eliminate or lessen health disparities and inequities.

On behalf of NIH, we invite you to share your perspective and recommendations as we thoughtfully consider our proactive approach to address racial and health inequities in biomedical research. Comments can be submitted through the submission website and must be received by April 9, 2021.

Please read NCI’s statement, in support of ending structural racism in biomedical research in its entirety.

As we continue to support NIH with the UNITE initiative and further develop our own initiatives to help combat this systemic issue at NCI, we will continue to update you and invite the communities’ input and recommendations.
Weekly NIH Funding Opportunities and Notices
COVID-19 Funding Opportunities and Notices
Have something to share?
Use the button below to submit all your news, publications, events, announcements, lab openings and communications requests to the Case CCC Marketing and Communications team! We are here to help.